Crystal structure of human catecholamine sulfotransferase

被引:95
作者
Bidwell, LM
McManus, ME
Gaedigk, A
Kakuta, Y
Negishi, M
Pedersen, L
Martin, JL [1 ]
机构
[1] Univ Queensland, Ctr Drug Design & Dev, Brisbane, Qld 4072, Australia
[2] Univ Queensland, Dept Physiol & Pharmacol, Brisbane, Qld 4072, Australia
[3] Childrens Mercy Hosp, Dept Clin Pharmacol & Toxicol, Kansas City, MO 64108 USA
[4] NIEHS, Pharmacogenet Sect, Reprod & Dev Toxicol Lab, NIH, Res Triangle Pk, NC 27709 USA
基金
澳大利亚研究理事会; 英国医学研究理事会; 美国国家卫生研究院;
关键词
dopamine; SULT1A3; sulfotransferase; protein structure; catecholamine;
D O I
10.1006/jmbi.1999.3153
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Sulfonation, like phosphorylation, can modify the activity of a variety of biological molecules. The sulfotransferase enzymes sulfonate neurotransmitters, drugs, steroid hormones, dietary carcinogens and proteins. SULT1A3 specifically sulfonates catecholamines such as dopamine, adrenaline and noradrenaline. The crystal structure of SULT1A3 with a sulfate bound at the active site, has been determined at 2.4 Angstrom resolution. Although the core alpha/beta fold is like that of estrogen and heparan sulfotransferases, major differences occur in and around the active site. Most notably, several regions Surrounding the active site, including a section of 40 residues, are disordered in SULT1A3. Regions that are topologically equivalent to the disordered parts of SULT1A3 are involved in substrate and cofactor binding in estrogen and heparan sulfotransferase. Flexibility in these regions suggests that ligand binding elicits a disorder-order transition in and around the active site of sulfotransferases and might contribute to the broad substrate specificity of these enzymes. (C) 1999 Academic Press.
引用
收藏
页码:521 / 530
页数:10
相关论文
共 51 条
[1]   Structure of a human lysosomal sulfatase [J].
Bond, CS ;
Clements, PR ;
Ashby, SJ ;
Collyer, CA ;
Harrop, SJ ;
Hopwood, JJ ;
Guss, JM .
STRUCTURE, 1997, 5 (02) :277-289
[2]   Analysis of the substrate specificity of human sulfotransferases SULT1A1 and SULT1A3: Site-directed mutagenesis and kinetic studies [J].
Brix, LA ;
Barnett, AC ;
Duggleby, RG ;
Leggett, B ;
McManus, ME .
BIOCHEMISTRY, 1999, 38 (32) :10474-10479
[3]   Structural characterization of human aryl sulphotransferases [J].
Brix, LA ;
Duggleby, RG ;
Gaedigk, A ;
McManus, ME .
BIOCHEMICAL JOURNAL, 1999, 337 :337-343
[4]  
Brunger A.T., 1992, X PLOR VERSION 3 1 M
[5]   THE BICUCULLINE-LIKE PROPERTIES OF DOPAMINE SULFATE IN RAT-BRAIN [J].
BUU, NT ;
DUHAIME, J ;
KUCHEL, O .
LIFE SCIENCES, 1984, 35 (10) :1083-1090
[6]  
Cowtan K., 1994, JOINT CCP4 ESF EACBM, V31, P34
[7]   REVERSE TURN AS A POLYPEPTIDE CONFORMATION IN GLOBULAR PROTEINS [J].
CRAWFORD, JL ;
LIPSCOMB, WN ;
SCHELLMAN, CG .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1973, 70 (02) :538-542
[8]   A single amino acid, Glu146, governs the substrate specificity of a human dopamine sulfotransferase, SULT1A3 [J].
Dajani, R ;
Hood, AM ;
Coughtrie, MWH .
MOLECULAR PHARMACOLOGY, 1998, 54 (06) :942-948
[9]   SETOR - HARDWARE-LIGHTED 3-DIMENSIONAL SOLID MODEL REPRESENTATIONS OF MACROMOLECULES [J].
EVANS, SV .
JOURNAL OF MOLECULAR GRAPHICS, 1993, 11 (02) :134-&
[10]   PURIFICATION AND CHARACTERIZATION OF HUMAN LIVER PHENOL-SULFATING PHENOL SULFOTRANSFERASE [J].
FALANY, CN ;
VAZQUEZ, ME ;
HEROUX, JA ;
ROTH, JA .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1990, 278 (02) :312-318